New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ZIOP;LVLT;QCOM;BCS;VAL;KORS;AVP;FB;NTWK;BYD;FOSL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
January 21, 2015
05:53 EDTQCOMStocks with implied volatility movement; IBM QCOM
Stocks with implied volatility movement; IBM (IBM) 27, Qualcomm (QCOM) 33 according to iVolatility.
05:53 EDTQCOMSamsung drops Qualcomm chip from next Galaxy smartphone, Bloomberg reports
Subscribe for More Information
05:30 EDTLVLTLevel 3 upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
January 20, 2015
13:21 EDTZIOPCAR T-Cell therapy drug stocks down sharply following NY Times story
Shares of biotechnology companies that are developing chimeric antigen receptor T cells or CAR T therapy drugs are falling sharply after a New York Times story titled "Riding High, Biotech Firms Remain Wary." WHAT'S NEW: Over the weekend, the New York Times published the story that struck a cautionary tone on the CAR-T therapy drugs. In this form of cancer treatment the patients own immune system cells are genetically manipulated to battle tumors. The New York Times story noted that there were some notable outcomes in the treatment of leukemia and lymphoma with the CAR T treatments but highlighted that the "technique is still early in development and can cause severe side effects." WHAT'S NOTABLE. Early last week, Intrexon (XON) and its oncology partner, ZIOPHARM Oncology (ZIOP), announced an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sub-licensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies. Both companies' shares were up sharply following the announcement ZIOPHARM was up around 55% and Intrexon up over 30% the day following the announcement. PRICE ACTION: Shares of drug companies in the space are sharply lower in midday trading, with ZIOPHARM Oncology and Kite Pharma (KITE) each down over 9%, Intrexon down almost 12%, and Bellicum Pharmaceutical (BLCM) and bluebird bio (BLUE) each down almost 5%. Reference Link
07:30 EDTBCSU.K. banks see Bitcoin as threat to sterling, boon to terrorists, Telegraph says
Subscribe for More Information
07:28 EDTBCSTreasury Institute for Higher Education to hold a symposium
Subscribe for More Information
06:57 EDTFBFacebook to upgrade Messenger app, experiment with revenue generation, WSJ says
Subscribe for More Information
06:57 EDTKORS, FOSLMichael Kors relative valuation looks compelling, says Piper Jaffray
Subscribe for More Information
06:41 EDTFOSLFossil downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Fossil to Neutral saying the company's North American growth could slow further while foreign currency is a headwind with a third of its sales coming from Europe. Piper lowered its price target for shares to $104 from $133.
06:09 EDTAVPAvon Products implied volatility of 76 at upper end of index mean range
Subscribe for More Information
06:02 EDTFBFacebook acquires boutique firm Teehan+Lax, terms not disclosed
Toronto-based boutique firm Teehan+Lax announced in a blog post on Friday that the company will join Facebook's design team in California. T+L said "In a few weeks we will be moving to the San Francisco Bay Area. This will mean saying goodbye to family, friends, Toronto, and Teehan+Lax." Terms of the deal have not been disclosed. Reference Link
05:54 EDTZIOPStocks with implied volatility movement; ZIOP INVN
Subscribe for More Information
January 18, 2015
16:34 EDTFBFacebook job listings hint at push into virtual reality, Reuters says
Subscribe for More Information
16:16 EDTBCSBarclays loses 'millions' on Swiss franc volatility, Reuters says
Subscribe for More Information
January 16, 2015
10:14 EDTZIOPZiopharm mentioned cautiously by TheStreetSweeper blog
Subscribe for More Information
10:01 EDTQCOMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:01 EDTKORSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 21st Century Fox (FOXA) initiated with a Buy at Stifel... Arista Networks (ANET) initiated with a Neutral at Buckingham... Boston Beer (SAM) initiated with a Buy at Jefferies... Brocade (BRCD) initiated with a Neutral at Buckingham... CBS (CBS) initiated with a Buy at Stifel... Cabela's (CAB) initiated with an Outperform at Raymond James... Coach (COH) initiated with a Market Perform at Bernstein... Costco (COST) initiated with an Outperform at BMO Capital... Crane (CR) initiated with a Hold at Canaccord... Flowserve (FLS) initiated with a Neutral at Susquehanna... Fortinet (FTNT) initiated with a Buy at Buckingham... Gap (GPS) initiated with a Market Perform at Bernstein... GrubHub (GRUB) initiated with a Buy at Stifel... Imperva (IMPV) initiated with a Neutral at Buckingham... KLX Inc. (KLXI) initiated with a Sector Perform at RBC Capital... KNOT Offshore Partners (KNOP) initiated with a Buy at UBS... L Brands (LB) initiated with a Market Perform at Bernstein... Michael Kors (KORS) initiated with an Outperform at Bernstein... Northstar Realty (NRF) initiated with a Buy at Sterne Agee... OmniVision (OVTI) initiated with a Buy at Rosenblatt... Qorvo (QRVO) initiated with a Buy at Brean ... RSP Permian (RSPP) initiated with an Outperform at Northland... Ross Stores (ROST) initiated with a Market Perform at Bernstein... SPX Corp. (SPW) initiated with a Neutral at Susquehanna... TJX (TJX) initiated with an Outperform at Bernstein... Tiffany (TIF) initiated with a Market Perform at Bernstein... Viacom (VIAB) initiated with a Buy at Stifel... Xylem (XYL) initiated with a Neutral at Susquehanna... iGATE (IGTE) initiated with a Buy at Deutsche Bank... lululemon (LULU) initiated with an Outperform at Bernstein.
09:09 EDTBCSDeutsche Bank, Barclays lost 'tens of millions' on Swiss franc, WSJ says
Subscribe for More Information
08:24 EDTQCOMQualcomm downgraded to Hold from Buy at Drexel Hamilton
Subscribe for More Information
06:03 EDTQCOMQualcomm Snapdragon 810 scheduled for product launches, DigiTimes reports
Although Qualcomm's Snapdragon 810 has been rumored to have defects and unstable mass production, DigiTimes Research says the product has already entered mass production. The AP may still have some defects, but they have not stopped vendors from adopting it into their products. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use